TCT 23 - We are joined by Dr Bernardo Cortese (Ospedale Fate bene Fratelli, IT) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.

Trials covered in detail include:
PARTNER 3
Evolut Low Risk
LIFE-BTK
AGENT-IDE
TRANSFORM I

Recorded remotely from Milano, 2023.

Editor: Jordan Rance
Video Specialist: Dan Brent